✦ LIBER ✦

CacyBP/SIP Expression is Involved in the Clinical Progression of Breast Cancer

✍ Scribed by Ningju Wang; Qingyong Ma; Yinna Wang; Gang Ma; Huihong Zhai

Publisher: Springer
Year: 2010
Tongue: English
Weight: 412 KB
Volume: 34
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s00268-010-0690-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The gene expression signature of genomic

The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome

✍ Jens K. Habermann; Jana Doering; Sampsa Hautaniemi; Uwe J. Roblick; Nana K. Bünd 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 899 KB

## Abstract Recently, expression profiling of breast carcinomas has revealed gene signatures that predict clinical outcome, and discerned prognostically relevant breast cancer subtypes. Measurement of the degree of genomic instability provides a very similar stratification of prognostic groups. We

Polycomb group protein EZH2 is frequentl

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome

✍ Yun Gong; Lei Huo; Ping Liu; Nour Sneige; Xiaoping Sun; Naoto T. Ueno; Anthony L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

## Abstract ## BACKGROUND: Enhancer of zeste homolog 2 (EZH2), a member of polycomb group proteins, is involved in the regulation of cell cycle progression and has been implicated in various human malignancies, including breast cancer, and also has been associated with aggressive tumor behavior. H

Expression of microRNA-221 is progressiv

Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

✍ Martin Spahn; Susanne Kneitz; Claus-Jürgen Scholz; Nico Stenger; Thomas Rüdiger; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 435 KB

## Abstract Emerging evidence shows that microRNAs (miR) are involved in the pathogenesis of a variety of cancers, including prostate carcinoma (PCa). Little information is available regarding miR expression levels in lymph node metastasis of prostate cancer or the potential of miRs as prognostic m

The expression of Fhit protein is relate

The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma

✍ Zoran Gatalica; Subodh M. Lele; B. Alan Rampy; Brent A. Norris 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

## BACKGROUND. The FHIT gene, located at human chromosome 3p14.2, frequently is deleted in a number of human tumors, including breast carcinoma. Its protein product (Fhit) is presumed to have tumor suppressor function. Loss of expression of a tumor suppressor gene is an important step in tumor prog

Involvement of DNA methylation in the co

Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers

✍ Valérie Martin; Stéphane Ribieras; Xiu-Gin Song-Wang; Yves Lasne; Lucien Frappar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

pS2 gene has been used to investigate the relationship between alterations of DNA methylation patterns in human tumors and gene expression. The expression of pS2, which is transcriptionally controlled by estrogens in breast cancer cell lines, is restricted to estrogen-receptor-rich human breast tumo

Osteopontin induces multiple changes in

Osteopontin induces multiple changes in gene expression that reflect the six “hallmarks of cancer” in a model of breast cancer progression

✍ Amy C. Cook; Alan B. Tuck; Susan McCarthy; Joel G. Turner; Rosalyn B. Irby; Greg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract Tumor progression is a multistep process, which enables cells to evolve from benign to malignant tumors. This progression has been suggested to depend on six essential characteristics identified as the “hallmarks of cancer,” which include: self‐sufficiency in growth signals, insensitivi